Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Nov 2021 07:00

RNS Number : 3102S
Cineworld Group plc
15 November 2021
 

FOR IMMEDIATE RELEASE

15 November 2021

 

Cineworld Group plc ("Cineworld" or the "Group")

Trading Update

Cineworld, the second largest cinema exhibitor in the world with operations in 10 countries including the United States and the United Kingdom and 752 sites and 9,193 screens globally, today provides the following update on trading across the Group for the four months ended 31 October 2021. This follows a period of unprecedented disruption in our industry and the world at large.

Since reopening our estate in April 2021, performance and attendances have steadily grown and this has resulted in revenue growth as seen in the table below. Customer demand has been particularly strong in a number of the Group's markets, in some cases even above the levels experienced in 2019.

Box office and Concession revenue(1) performance vs. 2019 were as follows:

2021 vs 2019

Jul

Aug

Sep

Oct

Group

50%

54%

60%

90%

United States

45%

45%

54%

80%

UK and Ireland

54%

76%

72%

127%

ROW

79%

70%

78%

84%

(1) Constant currency revenue

This recovery has been driven by an excellent slate of movies including "Black Widow", "Shang-Chi and the Legend of the Ten Rings", "Venom", "No Time to Die" and "Dune". There are still major blockbusters to be released in 2021 including "Ghostbusters: Afterlife", "Encanto", "Spider-Man: No Way Home", "The King's Man", "Sing 2" and "The Matrix Resurrections", which we anticipate will perform very well subject to there being no deterioration in the COVID-19 situation.

This revenue performance has been underpinned by discipline on costs where the company has been focused on streamlining operations wherever possible, although we have seen some inflationary cost increases.

As a result of this improvement in revenue and the cost measures implemented, the Group generated positive cash flow in October, an important milestone in the Company's recovery.

Mooky Greidinger, CEO commented: "We are thrilled to see audiences returning in significant numbers. Our partnerships with the studios are as strong as ever and with the incredible movie slate to come, there are real grounds for optimism in our industry. I would especially highlight the great performances we saw from our newly refurbished cinemas in the US. These new cinemas clearly support our strategy to enhance the cinema experience for all our customers. I am really proud of the extraordinary efforts that everybody in the business has made to manage this company during an unprecedented time. Whilst there are challenges ahead, I believe these efforts have positioned us for great success in the future and we are all looking forward to continuing to welcome our customers to the best place to watch a movie".

 

Cautionary note concerning forward looking statements

Certain statements in this announcement are forward looking and so involve risk and uncertainty because they relate to events, and depend upon circumstances that will occur in the future and therefore results and developments can differ materially from those anticipated. The forward looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

Contacts

Cineworld Group plc:

Finsbury:

Israel Greidinger

+44 (0)20 8987 5000

James Leviton

+44 (0)20 7251 3801

Nisan Cohen

investors@cineworld.co.uk

cineworld-lon@finsbury.com

Manuela Van Dessel

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFWEFLEFSESF
Date   Source Headline
31st Jul 20233:10 pmRNSEntry of Cineworld Group plc into Administration
28th Jul 20237:30 amRNSSuspension - Cineworld Group PLC
28th Jul 20237:00 amRNSSuspension of Cineworld’s Listing
29th Jun 20237:00 amRNSConfirmation of Plan of Reorganisation
26th Jun 20239:50 amRNSDirector Declaration
26th Jun 20237:00 amRNSChapter 11 Update
25th May 20237:00 amRNSChapter 11 update
9th May 202312:24 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th Apr 202311:15 amRNSGeneral Meeting
18th Apr 20237:00 amRNSChapter 11 Update
11th Apr 20237:00 amRNSChapter 11 Update
3rd Apr 20237:00 amRNSChapter 11 Update
23rd Mar 20232:58 pmRNSNotice of General Meeting
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20237:00 amRNSUpdate on Chapter 11 cases
1st Feb 20234:35 pmRNSPrice Monitoring Extension
27th Jan 202312:49 pmRNSCommittee Changes
3rd Jan 20237:00 amRNSUpdate on Chapter 11 cases and marketing process
14th Dec 20221:00 pmRNSDirectorate Change
12th Dec 20225:32 pmRNSDirector Update
8th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Nov 20229:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Nov 20224:40 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20224:41 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20224:41 pmRNSSecond Price Monitoring Extn
14th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results for the period ended 30 June 2022
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20222:17 pmRNSUpdate Regarding Interim Results
20th Sep 20227:00 amRNSHolding(s) in Company
15th Sep 20229:33 amRNSHolding(s) in Company
15th Sep 20227:15 amRNSDirector Declaration
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:41 pmRNSSecond Price Monitoring Extn
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20228:21 amRNSReceives Court Approval for “First Day” Relief
8th Sep 20225:30 pmRNSCineworld Group
7th Sep 20223:45 pmRNSCommencement of Chapter 11 Cases
1st Sep 20229:54 amRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.